---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-163860"
form_type: "8-K"
ticker: "BHC"
cik: "0000885590"
company_name: "Bausch Health Companies Inc."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:57:46.965225+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bausch Health appoints Michael Goettler and Sandra Leung to Board, effective July 22, 2025

## Summary
- Board expands from 10 to 12 members with the addition of two new directors.
- Michael Goettler, former Viatris CEO, joins Talent & Compensation and Science & Technology Committees.
- Sandra Leung, former BMS EVP & General Counsel, joins Nominating & Corporate Governance Committee.
- Both appointees have extensive pharmaceutical industry leadership experience.

## SEC filing metadata
- accession: 0001193125-25-163860
- form_type: 8-K
- ticker: BHC
- cik: 0000885590
- company_name: Bausch Health Companies Inc.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000119312525163860/0001193125-25-163860-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000119312525163860/d862655d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-163860
- JSON: https://secwatch.observer/filing/0001193125-25-163860.json
- Plain text: https://secwatch.observer/filing/0001193125-25-163860.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.